Buy & Sell Mesoblast Limited (MESO) – Mesoblast Limited Price Today
Key Stats
- $1.89BMarket Cap
- TechnologySector
- -19.09%3M Drawdown
- $1.90BEnterprise Value
- -Dividend Yield
- 16 daysTypical Hold Time
Mesoblast Limited (MESO) is currently valued at a market capitalization of $1.89B, with an enterprise value of $1.90B. Over the past 52 weeks, Mesoblast Limited has traded between a low of $10.16 and a high of $20.96, highlighting its annual price range. Over the past three months, Mesoblast Limited has recorded a drawdown of -19.09%, reflecting recent price volatility. On average, investors hold Mesoblast Limited for approximately 16 days, indicating typical investor behavior on the platform.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Most Recent News
US Golden Dome missile defense plan faces criticism over cost and arms race risks.
The US Golden Dome missile-defense system, designed to protect against ballistic, hypersonic, and cruise missiles, is under fire from Democrats and arms-control advocates. Critics warn it could cost over $1 trillion in 20 years, potentially trigger a...

Nike shares rise as energy prices fall and bond yields ease, boosting consumer stocks.
Nike's stock climbed over 4% following a drop in crude oil prices and a slight decrease in long-term Treasury yields, which eased borrowing costs and improved market sentiment. The retreat in energy prices and bond yields helped revive confidence in ...

Figure Technology Solutions to present at two major investor conferences in May and June 2026
Figure Technology Solutions, a leader in blockchain-native capital marketplaces, announced it will present at the Bernstein 42nd Annual Strategic Decisions Conference on May 27, 2026, and the Piper Sandler Global Exchange & FinTech Conference on June...
